MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.68 -0.60%

-$0.09 today

Market cap
$176.61M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.16M

Average 0.09M

Returns on capital

MediWound Ltd. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-54.7%

avg -66.3%

ROIC

-41.3%

avg -39.8%

ROA

-27.7%

avg -32.0%

Analysis

ROA is currently the strongest return metric at -27.7% versus its period average of -32.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Ofer Gonen

Chief Executive OfficerUSD 834K530<0.01%

Ety Klinger

Chief Medical OfficerUSD 428K641.50K0.01%

Shmulik Hess

Chief Operating Officer & Chief Commercial OfficerUSD 426K52——

Hani Luxenburg

Chief Financial OfficerUSD 420K52——

Yaron Meyer Adv.

Executive Vice President, General Counsel & Corporate SecretaryUSD 337K47——

Liron Gal

Vice President of Manufacturing Science & Technology————

Robert J. Snyder FFPM

Senior Vice President of Global Medical Affairs—75——

Barry J. Wolfenson

Executive Vice President of Strategy & Corporate Development—59——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 11, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

7

$142,671.19

Sells

4

$82,072.23

Net Transaction Value

+$60,598.96

Net buying

Most Active

Rubinstein Samuel

3 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 1, 26

Rubinstein Samuel

Indirect

Buy$6.6K
Sep 1, 26

Rubinstein Samuel

Indirect

Sell$6.7K
Aug 27, 26

Hess Shmuel

Direct

Sell$25.2K
Aug 27, 26

Hess Shmuel

Direct

Sell$26K
Aug 26, 26

Hess Shmuel

Direct

Sell$24.2K
Jun 3, 26

SHAMIR NACHUM

Direct

Buy$2.4K
Jun 3, 26

SHAMIR NACHUM

Direct

Buy$81.6K
Jun 1, 26

Fox David Morton

Direct

Buy$25.1K
Jun 1, 26

Fox David Morton

Direct

Buy$24.6K
Jun 1, 26

Fox David Morton

Direct

Buy$142.3

1–10 of 11

Summary

Insiders reported 7 buys worth $142,671.19 and 4 sells worth $82,072.23 over the last 12 months. That adds up to net buying of $60,598.96. Rubinstein Samuel was the most active insider with 3 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-13.8%
+59.0% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at -13.8% over three years. Forward estimates point to Revenue at +59.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does MediWound Ltd. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about MDWD's management, answered from reported figures.

Who manages MDWD?

MediWound Ltd. (MDWD) lists 8 active executives. The top listed executive is Ety Klinger, Chief Medical Officer.

Are MDWD insiders buying or selling?

Recent insider activity shows net selling of $69,468.24.